Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
567.74
+7.98 (1.43%)
At close: Jul 11, 2025, 4:00 PM
567.06
-0.68 (-0.12%)
After-hours: Jul 11, 2025, 6:10 PM EDT
Regeneron Pharmaceuticals Analyst Ratings
Total Analysts
22
Consensus Rating
Buy
Price Target
$840.95
Upside
+48.12%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $560 → $584 | Hold | Maintains | $560 → $584 | +2.86% | Jul 11, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $755 → $754 | Buy | Maintains | $755 → $754 | +32.81% | Jul 10, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $950 → $800 | Buy | Maintains | $950 → $800 | +40.91% | Jun 9, 2025 |
| UBS | UBS | Hold Maintains $633 → $560 | Hold | Maintains | $633 → $560 | -1.36% | Jun 5, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $700 → $650 | Strong Buy | Maintains | $700 → $650 | +14.49% | Jun 2, 2025 |
| BMO Capital | BMO Capital | Buy Maintains $800 → $600 | Buy | Maintains | $800 → $600 | +5.68% | Jun 2, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $958 → $755 | Buy | Maintains | $958 → $755 | +32.98% | Jun 2, 2025 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $700 → $580 | Buy → Hold | Downgrades | $700 → $580 | +2.16% | May 30, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $943 | Buy | Reiterates | $943 | +66.10% | May 27, 2025 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $600 → $700 | Hold → Strong Buy | Upgrades | $600 → $700 | +23.30% | May 14, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $1,081 → $958 | Buy | Maintains | $1,081 → $958 | +68.74% | May 5, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $940 → $810 | Strong Buy | Maintains | $940 → $810 | +42.67% | May 1, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $1,000 → $950 | Buy | Maintains | $1,000 → $950 | +67.33% | Apr 30, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $975 → $940 | Strong Buy | Maintains | $975 → $940 | +65.57% | Apr 30, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $917 → $804 | Strong Buy | Maintains | $917 → $804 | +41.61% | Apr 30, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $1,051 → $943 | Buy | Maintains | $1,051 → $943 | +66.10% | Apr 30, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.